Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Oppe

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Pharmacoeconomics|January 9, 2020
A French Value Set for the EQ-5D-5LLuiz Flavio Andrade, Kristina Ludwig, Juan Manuel Ramos Goni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Quality Control Process for EQ-5D-5L Valuation StudiesJuan M Ramos-Goñi, Mark Oppe, Bernhard Slaap, et al.
Plos One|February 3, 2017
Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomesPepijn Vemer, Maiwenn J Al, Mark Oppe, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
Time to tweak the TTO: results from a comparison of alternative specifications of the TTOMatthijs M Versteegh, Arthur E Attema, Mark Oppe, et al.
Health and Quality of Life Outcomes|August 2, 2015
Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statementStavros Petrou, Oliver Rivero-Arias, Helen Dakin, et al.
International Journal of Technology Assessment in Health Care|August 4, 2015
PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENTStavros Petrou, Oliver Rivero-Arias, Helen Dakin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 21, 2021
Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analysesMark Oppe, Daniela Ortín-Sulbarán, Carlos Vila Silván, et al.
Health Economics|March 8, 2012
Lead time TTO: leading to better health state valuations?Arthur E Attema, Matthijs M Versteegh, Mark Oppe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 16, 2009
Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional researchJan B Oostenbrink, Maiwenn J Al, Mark Oppe, et al.
Journal of Medical Economics|August 22, 2015
Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statementStavros Petrou, Oliver Rivero-Arias, Helen Dakin, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Pharmacoeconomics|January 9, 2020
A French Value Set for the EQ-5D-5LLuiz Flavio Andrade, Kristina Ludwig, Juan Manuel Ramos Goni, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 16, 2017
Quality Control Process for EQ-5D-5L Valuation StudiesJuan M Ramos-Goñi, Mark Oppe, Bernhard Slaap, et al.
Plos One|February 3, 2017
Mix and match. A simulation study on the impact of mixed-treatment comparison methods on health-economic outcomesPepijn Vemer, Maiwenn J Al, Mark Oppe, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 1, 2013
Time to tweak the TTO: results from a comparison of alternative specifications of the TTOMatthijs M Versteegh, Arthur E Attema, Mark Oppe, et al.
Health and Quality of Life Outcomes|August 2, 2015
Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statementStavros Petrou, Oliver Rivero-Arias, Helen Dakin, et al.
International Journal of Technology Assessment in Health Care|August 4, 2015
PREFERRED REPORTING ITEMS FOR STUDIES MAPPING ONTO PREFERENCE-BASED OUTCOME MEASURES: THE MAPS STATEMENTStavros Petrou, Oliver Rivero-Arias, Helen Dakin, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|April 21, 2021
Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analysesMark Oppe, Daniela Ortín-Sulbarán, Carlos Vila Silván, et al.
Health Economics|March 8, 2012
Lead time TTO: leading to better health state valuations?Arthur E Attema, Matthijs M Versteegh, Mark Oppe, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 16, 2009
Expected value of perfect information: an empirical example of reducing decision uncertainty by conducting additional researchJan B Oostenbrink, Maiwenn J Al, Mark Oppe, et al.
Journal of Medical Economics|August 22, 2015
Preferred reporting items for studies mapping onto preference-based outcome measures: The MAPS statementStavros Petrou, Oliver Rivero-Arias, Helen Dakin, et al.
Pageof 6